Isoprostanoids in Clinical and Experimental Neurological Disease Models

Isoprostanoids in Clinical and Experimental Neurological Disease Models

Isoprostanoids are a large family of compounds derived from non-enzymatic oxidation of polyunsaturated fatty acids (PUFAs). Unlike other oxidative stress biomarkers, they provide unique information on the precursor of the targeted PUFA. Although they were discovered about a quarter of century ago, t...

Full description

Bibliographic Details
Main Authors: Cinzia Signorini, Claudio De Felice, Jean-Marie Galano, Camille Oger, Silvia Leoncini, Alessio Cortelazzo, Lucia Ciccoli, Thierry Durand, Joussef Hayek, Jetty Chung-Yung Lee
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Antioxidants
Subjects:
isoprostanes
neuroprostanes
neurological diseases
biomarkers
Online Access:http://www.mdpi.com/2076-3921/7/7/88

Internet

http://www.mdpi.com/2076-3921/7/7/88

Similar Items